| 查看: 2036 | 回复: 57 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 chu_mouse 的 3 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
[交流]
清华药学院储凌课题组招聘有机化学、化学生物学、生物方向博后及研究助理
|
|||
|
About the PI Ling Chu was born and raised in Hefei, Anhui, China. He received a B.S. degree in Chemistry from the University of Science and Technology of China in 2012. He completed his Ph.D. study at the Scripps Research Institute, where he conducted research with Prof. Jin-Quan Yu on the development of Palladium-catalyzed C-H activation reactions. After completing his Ph.D. in 2017, he switched his research field to chemical biology and worked with Prof. Alanna Schepartz and Prof. Derek Toomre as a Brown-Coxe postdoctoral fellow at Yale School of Medicine. In the Schepartz/Toomre lab, he developed new chemical biology tools for two-color long-time lapse live-cell super-resolution imaging. He then joined Prof. Craig Crews’ lab in 2019 as a postdoctoral associate, where he led the development of first PROTAC capable of degrading oncogenic KRASG12C. Ling will join School of Pharmaceutical Sciences, Tsinghua University as an assistant professor in 2021. His research interest lies at the interface of chemistry and biology. Website: chu-lab.org Email: chu_lab@126.com About the research New chemical biology tools to explore the beyond-rule-of-5 drug space There is an increasing need to pursuit less druggable targets that offer high potential for the development of new therapeutic agents and may require beyond-rule-of-5 (bRo5) molecules in order to take advantage of these opportunities. Nevertheless, bRo5 chemical space remains relatively unexplored, most likely due to the perceived non-oral properties, increased complexity of compounds in this space and the synthetic chemistry challenges associated with its navigation. There is a pressing need to develop new technologies for the discovery and oral delivery of bRo5 drugs. We will develop new chemical biology approaches that enable phenotypic screening of large, de novo bRo5 compound libraries inside living cells. Such efforts could potentially yield novel hits for “undruggable” targets. The strategies used here will be further pursued for applications in oral delivery of bRo5 compounds. Affecting protein stability as a new strategy to target KRAS The Kirsten rat sarcoma viral oncogene homologue (KRAS) gene is one of the most frequently mutated oncogenes in cancer. KRAS is mutated in ~30% of human cancers and is one of the most sought-after targets for pharmacological modulation. Despite its well-recognized importance in cancer malignancy, continuous efforts in the past three decades failed to develop approved therapies for KRAS mutant cancer. Recent efforts in direct targeting KRASG12C have resulted in small molecule inhibitors that showed great promise in early clinical trials. However, G12C mutant only represents a small percentage of patients with oncogenic KRAS mutations. To explore a general strategy to target KRAS, we will combine chemical screen and genetic screen to identify small molecules and genes that can destabilize KRAS across different mutant KRAS cell lines. Results from these screens will provide novel therapeutic leads and mechanistic insights of KRAS degradation pathway. Leveraging these findings, we hope to develop next-gen small molecule therapeutics for the treatment of KRAS mutant cancer. New tools for live-cell protein labeling and super-resolution imaging Proteins are the essential components in cell function. To understand the function of proteins in living cells, it is important to know the properties of proteins in the temporal and spatial context of the cell. Currently, live-cell protein labeling and imaging technologies have several limitations: 1) Widely adopted tools for live-cell protein labeling have a large size (20-30kDa), giving rise to concerns that they may interfere with protein folding, trafficking, activity, and interactions; 2) Fluorescence proteins or small molecule dyes bleach quickly under super-resolution imaging conditions, thus prevent long-term protein imaging. To solve these problems, we will develop short peptide tags for site-specific protein labeling in live cells. Such tags contain only a few amino acids and will have minimal perturbation of protein function in live cells. We will also develop bleaching-resistant live cell protein imaging tools that allow biologists to visualize the dynamics of proteins at the nanoscopy level (resolution<50 nm) with unlimited “photon budget”. Training We are an interdisciplinary research group working at the interface of chemistry and biology. Students in the lab will receive multidisciplinary training in experimental techniques ranging from synthetic chemistry to fluorescence microscopy to cellular studies. Representative skill sets in the group are given below. Chemical tools: organic synthesis, catalysts, medicinal chemistry, peptide synthesis Cell culture: mammalian cell lines, primary cell cultures Cell imaging: Confocal microscopy, STED, single-molecule microscopy, flow cytometry Molecular biology: Cloning, PCR, CRISPR Biochemistry: Protein purification, western blotting About the job We are actively recruiting. If you are passionate about chemical biology and drug discovery, come join us! Don’t hesitate to reach out to Dr. Chu at chu_lab@126.com Postdoc positions in biology Candidates should hold a PhD degree in cell biology, biochemistry, chemical biology, pharmacology or related fields. Experiences in phenotypic high-throughput assay or CRISPR screen are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Postdoc positions in chemistry Candidates should hold a PhD degree in organic chemistry, medicinal chemistry or related fields. Experiences in transition-metal catalysts are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Research assistants/Technicians Candidates should hold an MS or BS degree in chemistry or biology. If you are interested in joining the lab, please send your CV and contact information of three referees to Dr. Chu at chu_lab@126.com. Competitive salaries will be provided for qualified applicants. [ Last edited by chu_mouse on 2020-11-1 at 02:29 ] |
» 猜你喜欢
2026年申博-电池方向
已经有4人回复
26年博士申请自荐-电催化
已经有9人回复
申博自荐
已经有9人回复
研究生做的很差,你们会让毕业吗?
已经有11人回复
求碳排放博导;方向是LCA、生命周期可持续发展以及碳排放
已经有7人回复
2026博士申请求助
已经有4人回复
2026博士或科研助理转27年博士
已经有7人回复
急招2026年9月份入学博士
已经有3人回复
国自科送审了吗
已经有11人回复
博士招生
已经有5人回复
» 抢金币啦!回帖就可以得到:
坐标南京,诚租女友
+5/9281
昆明理工大学交通载运车辆方向招收2026年秋季入学博士生2名
+3/162
有能报销版面费的老师合作发表SCI开源期刊吗?
+1/85
湖南师范大学化学化工学院李斌课题组招收2026级博士生
+1/82
太行山徒步之凌水河(一)
+1/79
招聘科研助理
+1/76
重庆大学药学院沈宏城课题组招聘弘深青年教师/博士后/科研助理
+1/49
上海大学 “生物有机电子材料及器件”团队副教授、博士后招聘
+1/39
上海大学先进耐火材料团队招收博士研究生多名
+1/35
北京航空航天大学拟招收2026博士研究生
+1/33
北京航空航天大学拟招收2026博士研究生
+1/31
2026年江西师范大学药学院陈芬儿院士课题组招收智能药学博士生
+1/27
211高校2026年入学博士名额
+1/12
又是一年基金申报,焦虑,某些学术大佬能不能少点干预
+1/7
香港科技大学 招生 全奖博士 -- 机器人/电子/材料
+1/3
【急招】北京航空航天大学 | 超声脑机接口方向 | 2026年博士研究生
+1/3
天津医科大学基础医学院基础医学院2026级博士招生
+1/2
急招2026 博士|第2批 海南大学 |国家重大人才工程人才团队|2名
+1/2
北京理工大学团簇研究团队招聘博士后 (化学+材料)
+1/1
津工业大学郑柳春教授团队招有机化学方向的博士生
+1/1
15楼2020-10-30 08:02:10
18楼2020-10-31 11:45:21
42楼2020-11-15 11:00:56
简单回复
TTTiger2楼
2020-10-29 10:55
回复
chu_mouse(金币+1): 谢谢参与
好 发自小木虫IOS客户端
tzynew3楼
2020-10-29 11:12
回复
chu_mouse(金币+1): 谢谢参与
8 发自小木虫Android客户端
tzynew4楼
2020-10-29 11:12
回复
tzynew5楼
2020-10-29 11:12
回复
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
icanspll7楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
howtoge8楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
yaqianye9楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
shehuifei10楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
zzhello11楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
likecitywo12楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
encryption13楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
ro1114楼
2020-10-29 12:50
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn16楼
2020-10-30 13:55
回复
chu_mouse(金币+1): 谢谢参与
顶 发自小木虫IOS客户端
chu_mouse17楼
2020-10-31 10:54
回复
Haibo_19楼
2020-10-31 12:15
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn20楼
2020-10-31 12:27
回复
psylhh21楼
2020-10-31 17:56
回复
chu_mouse(金币+1): 谢谢参与
chuwanglinyx22楼
2020-11-01 17:30
回复
chu_mouse23楼
2020-11-01 23:55
回复
chuwanglinyx24楼
2020-11-02 16:13
回复
chu_mouse25楼
2020-11-03 08:45
回复
chu_mouse26楼
2020-11-04 00:03
回复
chusihai27楼
2020-11-04 07:41
回复
chu_mouse28楼
2020-11-05 08:53
回复
chuwanglinyx29楼
2020-11-05 15:29
回复
chusihai30楼
2020-11-06 05:40
回复
chuwanglinyx31楼
2020-11-06 19:06
回复
chuwanglinyx32楼
2020-11-08 08:25
回复
chuwanglinyx33楼
2020-11-10 14:40
回复
chu_mouse34楼
2020-11-11 12:25
回复
chusihai35楼
2020-11-12 11:39
回复
chuwanglinyx36楼
2020-11-13 08:56
回复
chusihai37楼
2020-11-13 12:51
回复
蓉蓉番薯38楼
2020-11-13 18:31
回复
zhx202012339楼
2020-11-13 20:46
回复
chusihai40楼
2020-11-14 12:08
回复
zhx202012341楼
2020-11-15 07:00
回复
chuwanglinyx43楼
2020-11-16 10:31
回复
chu_mouse44楼
2020-11-16 11:09
回复
chusihai45楼
2020-11-17 06:09
回复
chuwanglinyx46楼
2020-11-17 15:28
回复
chusihai47楼
2020-11-18 06:03
回复
chu_mouse48楼
2020-11-19 11:34
回复
chusihai49楼
2020-11-19 22:57
回复
zhx202012350楼
2020-11-21 10:10
回复












回复此楼
